Chemoinformaics analysis of salicylic acid-methyl-ester
| Molecular Weight | 195.174 | nRot | 2 |
| Heavy Atom Molecular Weight | 186.102 | nRig | 8 |
| Exact Molecular Weight | 195.053 | nRing | 1 |
| Solubility: LogS | -1.839 | nHRing | 0 |
| Solubility: LogP | 0.81 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 25.3391 |
| nHD | 1 | BPOL | 13.6669 |
| QED | 0.712 |
| Synth | 1.767 |
| Natural Product Likeliness | -0.301 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.59 |
| MDCK | 0.0000493 |
| BBB | 0.999 |
| PPB | 0.694222 |
| VDSS | 0.506 |
| FU | 0.361379 |
| CYP1A2-inh | 0.874 |
| CYP1A2-sub | 0.549 |
| CYP2c19-inh | 0.164 |
| CYP2c19-sub | 0.143 |
| CYP2c9-inh | 0.066 |
| CYP2c9-sub | 0.639 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.368 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.187 |
| CL | 8.875 |
| T12 | 0.795 |
| hERG | 0.03 |
| Ames | 0.742 |
| ROA | 0.309 |
| SkinSen | 0.509 |
| Carcinogencity | 0.689 |
| EI | 0.267 |
| Respiratory | 0.027 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.876748 |